Seiren : Consolidated Financial Results for the Nine Months Ended December 31, 2021
February 02, 2022 at 06:09 am
Share
Disclaimer: This document is an English translation of the original in Japanese and has been prepared solely for reference purposes. In the event of any discrepancy between this English translation and the original, the original shall prevail.
Consolidated Financial Results
for the Nine Months Ended December 31, 2021
[Japanese GAAP]
February 2, 2022
Company name: SEIREN CO., LTD.
Stock exchange listing: Tokyo Stock Exchange
Securities code: 3569
URL: https://www.seiren.com/english/
Representative: Tatsuo Kawada, Representative Director, Chairman and C.E.O.
Contact: Koji Kawada, Director and Managing Executive Officer, Division Manager, Corporate Strategy Planning Division
Phone: +81-776-35-2111
Scheduled date of filing quarterly securities report: February 14, 2022
Scheduled date of commencing dividend payments: -
Availability of supplementary explanatory materials on quarterly financial results: Available
Schedule of quarterly financial results briefing session: Not scheduled
(Amounts of less than one million yen are rounded down.)
1. Consolidated Financial Results for the Nine Months Ended December 31, 2021 (April 1, 2021 - December 31, 2021)
(1) Consolidated Operating Results
(% indicates changes from the previous corresponding period.)
Net sales
Operating profit
Ordinary profit
Profit attributable to
owners of parent
Nine months ended
Million yen
%
Million yen
%
Million yen
%
Million yen
%
December 31, 2021
80,103
13.0
8,137
38.8
8,785
45.1
6,562
86.1
December 31, 2020
70,911
(22.2)
5,860
(26.3)
6,055
(28.9)
3,526
(42.1)
Note: Comprehensive
income: Nine months
ended December 31,
2021: 9,047 million yen
[368.6%]
Nine months ended December 31, 2020: 1,930 million yen [(57.7)%]
Basic earnings
Diluted earnings
per share
per share
Nine months ended
Yen
Yen
December 31, 2021
122.33
104.68
December 31, 2020
63.74
63.08
(2) Consolidated Financial Position
Total assets
Net assets
Equity ratio
Net assets per share
Million yen
Million yen
%
Yen
As of December 31, 2021
151,604
88,159
57.2
1,616.63
As of March 31, 2021
144,702
80,897
55.0
1,484.52
Reference: Equity: As of December 31, 2021: 86,757 million yen
As of March 31, 2021: 79,623 million yen
These quarterly financial results are outside the scope of quarterly review by certified public accountants or an audit firm.
Explanation of the proper use of financial results forecast and other notes
The financial results forecasts and other forward-looking statements herein are based on information available to the Company as of the date of publication of this document and certain assumptions deemed reasonable. Actual results may differ significantly from these forecasts due to a wide range of factors. For notes on financial results forecasts, please refer to "1. Qualitative Information on Quarterly Financial Results for the Period under Review,
Explanation on Consolidated Financial Results Forecast and Other Forward-looking Information" on page 4 of the attachments to the Japanese version of this document.
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Seiren Co. Ltd. published this content on 02 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 February 2022 06:08:11 UTC.
Seiren Co Ltd is mainly engaged in the vehicle materials, high fashion, electronics, environment and living materials, and medical businesses. The Company operates through five segments. The Vehicle Material segment manufactures and sells automotive sheet materials and airbags. The High Fashion segment offers various apparel textile products and synthetic fabrics. The Electronics segment manufactures and sells electromagnetic shielding materials, sells Viscotex systems, and manufactures and sells satellites and satellite parts. The Environment and Living Materials segment manufactures and sells construction materials, interior materials, health and nursing care products, and various living and living materials. The Medical segment manufactures and sells cosmetics and medical base materials. In addition, the Company is also engaged in software development and sales, insurance agency business, temporary staffing business, and real estate rental management business.